Literature DB >> 23800976

Verapamil in infants: an exaggerated fear?

Martin J Lapage1, David J Bradley, Macdonald Dick.   

Abstract

The use of intravenous verapamil for tachyarrhythmia in infants is widely considered contraindicated due to the perceived risk of hemodynamic collapse after administration. This article reviews the relatively limited evidence that led to this well-known contraindication and highlights the interesting process by which medical practice may evolve in the absence of persuasive science.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23800976     DOI: 10.1007/s00246-013-0739-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  14 in total

1.  Intravenous verapamil in the treatment of paroxysmal supraventricular tachycardia in children.

Authors:  R P Leitner; R E Hawker; J M Celermajer
Journal:  Aust Paediatr J       Date:  1983-03

2.  Side effects of verapamil in infants.

Authors:  D Radford
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

3.  Effect of verapamil in infants with paroxysmal supraventricular tachycardia.

Authors:  J Soler-Soler; J Sagristá-Sauleda; A Cabrera; J Sauleda-Parés; J Iglesias-Berengué; G Permanyer-Miralda; J Roca-Llop
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

4.  An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil.

Authors:  J S Garland; R J Berens; J D Losek; A D Wilson
Journal:  Pediatr Emerg Care       Date:  1985-12       Impact factor: 1.454

5.  Inhibitory effects of procainamide on sympathetic nerve activity in humans.

Authors:  R F Rea; M Hamdan; S J Schomer; D R Geraets
Journal:  Circ Res       Date:  1991-08       Impact factor: 17.367

Review 6.  Developmental cardiac electrophysiology recent advances in cellular physiology.

Authors:  G T Wetzel; T S Klitzner
Journal:  Cardiovasc Res       Date:  1996-02       Impact factor: 10.787

7.  Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia.

Authors:  M L Epstein; E A Kiel; B E Victorica
Journal:  Pediatrics       Date:  1985-04       Impact factor: 7.124

8.  Cardiovascular collapse after verapamil in supraventricular tachycardia.

Authors:  C R Kirk; J L Gibbs; R Thomas; R Radley-Smith; S A Qureshi
Journal:  Arch Dis Child       Date:  1987-12       Impact factor: 3.791

9.  Verapamil-sensitive ventricular tachycardia in an infant.

Authors:  Christopher Snyder; James Bishara; Rani Darling; Victor Lucas
Journal:  Congenit Heart Dis       Date:  2006-05       Impact factor: 2.007

10.  Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and children.

Authors:  E Shahar; Z Barzilay; M Frand
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

View more
  5 in total

Review 1.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

2.  Postnatal developmental changes in the sensitivity of L-type Ca2+ channel to inhibition by verapamil in a mouse heart model.

Authors:  Hironori Sagawa; Shinsuke Hoshino; Kengo Yoshioka; Wei-Guang Ding; Mariko Omatsu-Kanbe; Masao Nakagawa; Yoshihiro Maruo; Hiroshi Matsuura
Journal:  Pediatr Res       Date:  2018-04-18       Impact factor: 3.756

Review 3.  Potential role of the gut microbiota in synthetic torpor and therapeutic hypothermia.

Authors:  Claudia Sisa; Silvia Turroni; Roberto Amici; Patrizia Brigidi; Marco Candela; Matteo Cerri
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

4.  Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.

Authors:  Rachel S Meyers; Jennifer Thackray; Kelly L Matson; Christopher McPherson; Lisa Lubsch; Robert C Hellinga; David S Hoff
Journal:  J Pediatr Pharmacol Ther       Date:  2020

5.  Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma.

Authors:  T Abruzzo; K Abraham; K B Karani; J I Geller; S Vadivelu; J M Racadio; B Zhang; Z M Correa
Journal:  AJNR Am J Neuroradiol       Date:  2020-12-24       Impact factor: 3.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.